
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differentia... Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists. 詳細を表示
CARLSBAD, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced that management will participate in the following...
New biomarkers on track for commercial launch in January 2025 Preliminary financial results indicate record full-year revenue and AVISE CTD trailing twelve-month ASP, with improvements to adjusted...
CARLSBAD, Calif., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Exagen Inc., a leading provider of autoimmune testing, today announced the completion of its 1,000,000th AVISE CTD test, marking a significant...
CARLSBAD, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Exagen Inc., a leading provider of autoimmune testing, today announced the validation and regulatory submission for approval of new Systemic...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.9301 | 24.0342127704 | 3.8699 | 5.6992 | 3.86 | 343401 | 5.08740967 | CS |
4 | 1.63 | 51.4195583596 | 3.17 | 5.6992 | 2.76 | 211183 | 4.3758601 | CS |
12 | 1.74 | 56.862745098 | 3.06 | 6.21 | 2.76 | 187280 | 4.44077604 | CS |
26 | 1.2 | 33.3333333333 | 3.6 | 6.21 | 2.38 | 102315 | 4.15739185 | CS |
52 | 2.7 | 128.571428571 | 2.1 | 6.21 | 1.3003 | 72823 | 3.50027552 | CS |
156 | -3.76 | -43.9252336449 | 8.56 | 9.44 | 1.3003 | 51234 | 3.64119691 | CS |
260 | -14.86 | -75.5849440488 | 19.66 | 26.96 | 1.3003 | 49022 | 7.76139613 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約